Form 8-K - Current report:
SEC Accession No. 0000950170-24-083974
Filing Date
2024-07-16
Accepted
2024-07-16 17:00:11
Documents
11
Period of Report
2024-07-12
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20240712.htm   iXBRL 8-K 37661
  Complete submission text file 0000950170-24-083974.txt   148038

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tcon-20240712.xsd EX-101.SCH 23907
14 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20240712_htm.xml XML 4548
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

EIN.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 241120247
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)